PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
C. nutans cream showed a median clearance rate of 82%, compared to 97% for podophyllin [PMID:35783521]
Leaf extract significantly reduced fasting blood glucose and pancreatic β-cell apoptosis by inhibiting JNK activation [PMID:38549571]
Extract reduced expression of pro-inflammatory cytokines IL6, IL8, and CXCL10 in gingival fibroblast cells under high-glucose conditions [PMID:39193343]
Exhibits virucidal activities against HSV-1, HSV-2, VZV, and potentially SARS-CoV-2 [PMID:37445964, PMID:33949277]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 28198202 (2017) — Clinacanthus nutans: a review on ethnomedicinal uses, chemical constituents and pharmacological properties. · Pharmaceutical biology
- 2.PMID: 34135980 (2021) — Recent Advancement in Anticancer Activity of Clinacanthus nutans (Burm. f.) Lindau. · Evidence-based complementary and alternative medicine : eCAM
- 3.PMID: 37445964 (2023) — Antiviral and Immunomodulatory Activities of Clinacanthus nutans (Burm. f.) Lindau. · International journal of molecular sciences
- 4.PMID: 35684542 (2022) — Anti-Inflammatory Effects of Phytochemical Components of Clinacanthus nutans. · Molecules (Basel, Switzerland)
- 5.PMID: 28253196 (2017) — Cytotoxicity and cytochrome P450 inhibitory activities of Clinacanthus nutans.